NuVasive had to raise its litigation royalty expense estimate for the year after a U.S. District Court set royalty rates for the company’s CoRoent XL implants at 13.75 percent and MaXcess retractors ...
On March 12, the FDA issued a warning letter to NuVasive for selling Affix Spinous Process Plate systems for uses not approved by the device’s 510(k) clearance. The Affix system is approved to clamp ...
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF The peer-reviewed publication reiterates that the Simplify Disc ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-second-quarter-2023-financial-results-301891255.html SOURCE ...
SAN DIEGO, April 11, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a ...
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding in the overseas markets through the expansion of direct and ...
Biotronic, based in Ann Arbor, Mich., is a privately held company that provides intraoperative neurophysiological monitoring services to surgeons and healthcare facilities in the U.S. San Diego-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results